TNF and rheumatoid arthritis: These findings taken together suggest that the therapeutic effects of TNF inhibitors on chronic joint inflammation are variable in RA patients because of their heterogenous cellular responses via TNFR1 and TNFR2 signaling and variable compositions of synoviocytes and their expression of the two receptors.